Mapping the Progress of Alzheimer’s and Parkinson’s Disease: 51 (Advances in Behavioral Biology, 51) - Image 1

£152.96

Springer Mapping the Progress of Alzheimer’s and Parkinson’s Disease: 51 (Advances in Behavioral Biology, 51)

Name: Mapping the Progress of Alzheimer's and Parkinson's Disease: 51 (Advances in Behavioral Biology, 51)
Brand: Springer
Price: 152.99 GBP
Availability: InStock

Geriatrics

Price History & Forecast

Last 35 days • 35 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 35 days • 1 price levels

Days at Price

Price Analysis

Most common price: £153 (35 days, 100.0%)

Price range: £153 - £153

Price levels: 1 different prices over 35 days

Description

1h The 5 International Conference on the Progress in Alzheimer's Disease and Parkinson's 51 1 Disease took place from March 31 to April 5 \ 2001 in Kroto, Japan. This international 1 conference was organized as a joint Congress with the 9 International Catecholamine Symposium. A total of 1258 clinicians and researchers participated in this joint congress 1h from 38 countries in the world. This book represents the proceedings of the 5 Conference on Alzheimer's and Parkinson's disease. The International Conference on the Progress in Alzheimer's and Parkinson's disease was first launched by Professor Abraham Fisher of Israel and Professor Israel Hanin of USA. The first conference was held in Eilat, Israel in 1985. The second conference was organized in Kyoto, Japan in 1989; the third one in Chicago, USA, in 1993, and the fourth one in Eilat, Israel in 1997. The International Catecholamine Symposium (ICS) is an international meeting devoted to the development of basic as well as clinical research on catecholamines. The first Catecholamine Symposium was held in Bethesda, USA in 1958. Since then this symposium has occurred every 5 years. Professor Toshiharu Nagatsu was appointed as 1h the president of the 9 International Catecholamine Symposium, which was to be held in 200 I also in Japan. Therefore, we decided to organize a joint congress of the two meetings, because there is much overlap in research between Alzheimer's disease, Parkinson's disease, and catecholamines. We thank Professor Nagatsu very much for agreeing to organizing this joint congress.

Product Specifications

Brand: Springer
Format: Hardcover
ASIN: 0306467631
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Internal Medicine > Geriatrics
Domain: Amazon UK
Release Date: 31 March 2002
Listed Since: 07 February 2007

Barcode

No barcode data available

Springer Mapping the Progress of Alzheimer’s and Parkinson’s Disease: 51 (Advances in Behavioral Biology, 51)

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Mapping the Progress of Alzheimer’s and Parkinson’s Disease: 51 (Advances in Behavioral Biology)

Catecholamine Research: From Molecular Insights to Clinical Medicine: 53 (Advances in Behavioral Biology, 53)

Catecholamine Research: From Molecular Insights to Clinical Medicine: 53 (Advances in Behavioral Biology, 53)

Progress in Alzheimer’s and Parkinson’s Diseases: 49 (Advances in Behavioral Biology, 49)

Alzheimer’s and Parkinson’s Diseases: Recent Developments: 44 (Advances in Behavioral Biology, 44)

Alzheimer’s and Parkinson’s Diseases: Recent Developments: 44 (Advances in Behavioral Biology, 44)

Advances in Alzheimer's and Parkinson's Disease: Insights, Progress, and Perspectives: 57 (Advances in Behavioral Biology, 57)

Advances in Alzheimer's and Parkinson's Disease: Insights, Progress, and Perspectives: 57 (Advances in Behavioral Biology, 57)

Recent Progress in Alzheimer's and Parkinson's Diseases

Current Hypotheses and Research Milestones in Alzheimer's Disease

Staging Neuropsychiatric Disorders: Implications for Etiopathogenesis and Treatment: 5 (Current Topics in Neurotoxicity)

Intracellular Traffic and Neurodegenerative Disorders (Research and Perspectives in Alzheimer's Disease)

Neurodegenerative Diseases: Clinical Aspects, Molecular Genetics and Biomarkers

Staging Neuropsychiatric Disorders: Implications for Etiopathogenesis and Treatment

The Central Catecholaminergic System - Neuroscience Research

Research Progress in Alzheimer's Disease And Dementia: 1: v. 1: Volume 1

Reviews on Biomarker Studies in Psychiatric and Neurodegenerative Disorders: 1118 (Advances in Experimental Medicine and Biology, 1118)

Recent Advances in Parkinsons Disease: Part I: Basic Research (Progress in Brain Research): Volume 183

Springer - Staging Neuropsychiatric Disorders Book

Neurotoxic Factors in Parkinson’s Disease and Related Disorders

The Adenosinergic System: A Non-Dopaminergic Target in Parkinson’s Disease: 10 (Current Topics in Neurotoxicity)

Two Faces of Evil: Cancer and Neurodegeneration (Research and Perspectives in Alzheimer's Disease)

Springer Proteopathic Seeds and Neurodegenerative Diseases

Neurochemical Aspects of Neurotraumatic and Neurodegenerative Diseases